Cargando…
Human Trabecular Meshwork Progenitors
Trabecular meshwork (TM) cells are a group of progenitors that have the ability to become adipocytes, chondrocytes and endothelial cells. Therefore, those adult corneal progenitors may be used as an effective therapy for trabecular meshwork diseases such as glaucoma, corneal endothelial dysfunctions...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566744/ https://www.ncbi.nlm.nih.gov/pubmed/31217738 http://dx.doi.org/10.7150/ijms.32089 |
_version_ | 1783426918920486912 |
---|---|
author | Zhu, Qin Zhang, Yuan Tighe, Sean Liu, Yongsong Zhu, Yingting Hu, Min |
author_facet | Zhu, Qin Zhang, Yuan Tighe, Sean Liu, Yongsong Zhu, Yingting Hu, Min |
author_sort | Zhu, Qin |
collection | PubMed |
description | Trabecular meshwork (TM) cells are a group of progenitors that have the ability to become adipocytes, chondrocytes and endothelial cells. Therefore, those adult corneal progenitors may be used as an effective therapy for trabecular meshwork diseases such as glaucoma, corneal endothelial dysfunctions such as blindness due to corneal endothelial dysfunction, and similar diseases. In order to promote the understanding of human trabecular meshwork progenitors, this article reviews human trabecular meshwork progenitor therapy and discusses its potential applications for curing human eye blindness. |
format | Online Article Text |
id | pubmed-6566744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-65667442019-06-19 Human Trabecular Meshwork Progenitors Zhu, Qin Zhang, Yuan Tighe, Sean Liu, Yongsong Zhu, Yingting Hu, Min Int J Med Sci Review Trabecular meshwork (TM) cells are a group of progenitors that have the ability to become adipocytes, chondrocytes and endothelial cells. Therefore, those adult corneal progenitors may be used as an effective therapy for trabecular meshwork diseases such as glaucoma, corneal endothelial dysfunctions such as blindness due to corneal endothelial dysfunction, and similar diseases. In order to promote the understanding of human trabecular meshwork progenitors, this article reviews human trabecular meshwork progenitor therapy and discusses its potential applications for curing human eye blindness. Ivyspring International Publisher 2019-05-10 /pmc/articles/PMC6566744/ /pubmed/31217738 http://dx.doi.org/10.7150/ijms.32089 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Zhu, Qin Zhang, Yuan Tighe, Sean Liu, Yongsong Zhu, Yingting Hu, Min Human Trabecular Meshwork Progenitors |
title | Human Trabecular Meshwork Progenitors |
title_full | Human Trabecular Meshwork Progenitors |
title_fullStr | Human Trabecular Meshwork Progenitors |
title_full_unstemmed | Human Trabecular Meshwork Progenitors |
title_short | Human Trabecular Meshwork Progenitors |
title_sort | human trabecular meshwork progenitors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566744/ https://www.ncbi.nlm.nih.gov/pubmed/31217738 http://dx.doi.org/10.7150/ijms.32089 |
work_keys_str_mv | AT zhuqin humantrabecularmeshworkprogenitors AT zhangyuan humantrabecularmeshworkprogenitors AT tighesean humantrabecularmeshworkprogenitors AT liuyongsong humantrabecularmeshworkprogenitors AT zhuyingting humantrabecularmeshworkprogenitors AT humin humantrabecularmeshworkprogenitors |